Drug interactions
Dabrafenib + Saxagliptin-metformin
Severity: Moderate
Dabrafenib and Saxagliptin-metformin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dabrafenib is a CYP3A4 inducer and can lower saxagliptin exposure, possibly weakening glycemic control. Dabrafenib itself is also associated with hyperglycemia, which may worsen diabetes control.
What this interaction means in plain words
Dabrafenib and Saxagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dabrafenib belongs to Oncology; Saxagliptin-metformin belongs to Endocrine.
Why it happens
Dabrafenib induces CYP3A4, increasing saxagliptin metabolism, and may independently raise blood glucose.
What to do
Monitor blood glucose and HbA1c closely during dabrafenib therapy and intensify antidiabetic treatment if control deteriorates. Re-evaluate doses when dabrafenib is discontinued.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dabrafenib and Saxagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Saxagliptin-metformin
Other interactions of Dabrafenib
Frequently asked questions
Can I take Dabrafenib with Saxagliptin-metformin?
MediHelp rates the interaction as moderate. Dabrafenib and Saxagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dabrafenib is a CYP3A4 inducer and can lower saxagliptin exposure, possibly weakening glycemic control. Dabrafenib itself is also associated with hyperglycemia, which may worsen diabetes control.
How serious is the interaction between Dabrafenib and Saxagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c closely during dabrafenib therapy and intensify antidiabetic treatment if control deteriorates. Re-evaluate doses when dabrafenib is discontinued.
What other medicines interact with Saxagliptin-metformin?
MediHelp also lists interactions of Saxagliptin-metformin with, for example, Atazanavir, Clozapine, Contrast media. The full list is on the Saxagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
